These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22351488)

  • 21. Clinical, genetic and regulatory consequences of exposure to mutagens.
    Rüdiger HW
    Ann Genet; 1991; 34(3-4):173-8. PubMed ID: 1809224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selecting chemicals and assays for assessing mammalian germ cell mutagenicity.
    Shelby MD
    Mutat Res; 1996 Jun; 352(1-2):159-67. PubMed ID: 8676905
    [No Abstract]   [Full Text] [Related]  

  • 23. The measurement of induced genetic change in mammalian germ cells.
    Adler ID; Pacchierotti F; Russo A
    Methods Mol Biol; 2012; 817():335-75. PubMed ID: 22147580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germ cell mutations in mice.
    Ehling UH
    IARC Sci Publ; 1989; (96):207-19. PubMed ID: 2680946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heritable hazards of smoking: Applying the "clean sheet" framework to further science and policy.
    Bline AP; Dearfield KL; DeMarini DM; Marchetti F; Yauk CL; Escher J;
    Environ Mol Mutagen; 2020 Nov; 61(9):910-921. PubMed ID: 33064321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Permanent embryonic mouse germ cell-lines, an in vitro alternative to in vivo germ cell mutagenicity tests].
    Klemm M; Genschow E; Pohl I; Barrabas C; Liebsch M; Spielmann H
    ALTEX; 2001; 18(2):127-30. PubMed ID: 11378688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic toxicity assessment: employing the best science for human safety evaluation part IV: Recommendation of a working group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing.
    Pfuhler S; Albertini S; Fautz R; Herbold B; Madle S; Utesch D; Poth A;
    Toxicol Sci; 2007 Jun; 97(2):237-40. PubMed ID: 17303579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A male germ cell assay and supporting somatic cells: its application for the detection of phase specificity of genotoxins in vitro.
    Habas K; Brinkworth MH; Anderson D
    J Toxicol Environ Health B Crit Rev; 2020 Apr; 23(3):91-106. PubMed ID: 32046612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trans-generational radiation-induced chromosomal instability in the female enhances the action of chemical mutagens.
    Camats N; García F; Parrilla JJ; Calaf J; Martín M; Caldés MG
    Mutat Res; 2008 Apr; 640(1-2):16-26. PubMed ID: 18206182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of the dominant lethal test in the freshwater mollusk Biomphalaria glabrata (Say, 1818).
    Nakano E; Watanabe LC; Ohlweiler FP; Pereira CA; Kawano T
    Mutat Res; 2003 Apr; 536(1-2):145-54. PubMed ID: 12694755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the toxicology of acrylamide.
    Exon JH
    J Toxicol Environ Health B Crit Rev; 2006; 9(5):397-412. PubMed ID: 17492525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Information requirements and regulatory approaches for heritable genetic risk assessment and risk communication.
    Dearfield KL
    Mutat Res; 1995 Aug; 330(1-2):35-40. PubMed ID: 7623869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying germ cell mutagens using OECD test guideline 488 (transgenic rodent somatic and germ cell gene mutation assays) and integration with somatic cell testing.
    Marchetti F; Aardema MJ; Beevers C; van Benthem J; Godschalk R; Williams A; Yauk CL; Young R; Douglas GR
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Aug; 832-833():7-18. PubMed ID: 30057023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germ-cell sensitivity in mammals.
    Adler ID
    Prog Clin Biol Res; 1982; 109():137-48. PubMed ID: 7167539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of germ cell mutagenicity in male CYP2E1-null and wild-type mice treated with acrylamide: evidence supporting a glycidamide-mediated effect.
    Ghanayem BI; Witt KL; El-Hadri L; Hoffler U; Kissling GE; Shelby MD; Bishop JB
    Biol Reprod; 2005 Jan; 72(1):157-63. PubMed ID: 15355880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mutagenesis moonshot: The propitious beginnings of the environmental mutagenesis and genomics society.
    DeMarini DM
    Environ Mol Mutagen; 2020 Jan; 61(1):8-24. PubMed ID: 31294870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Databases applicable to quantitative hazard/risk assessment--towards a predictive systems toxicology.
    Waters M; Jackson M
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):34-44. PubMed ID: 18675838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.